In its first-quarter 2026 results announcement, the company said it held a backlog of about KRW 28.5 billion at the end of the first quarter and expected results to improve gradually through the second half.
The second and third quarters, however, saw revenue fall for two consecutive quarters and operating losses persist, so whether this outlook materializes is the next point to check. On costs, a cost-reduction task force has operated since September 2026 with a target of a 30% reduction at the design stage.
Improvements in project-level cost ratios and product mix, along with growth in overseas maintenance revenue, are cited as key variables for restoring operating profit.
On business milestones, a supply contract worth about KRW 4.96 billion for ESS inspection equipment bound for the United States was signed in August 2026, and 46-series inline CT equipment shipped the same month.
Two FPCB inspection units for foldable smartphones have been supplied, with one more scheduled for delivery in the fourth quarter of 2026. Glass-substrate inspection is targeted to add meaningful revenue from 2027, and the next-generation helical CT is being developed for mass-production use in 2027.
HBM inline CT is in mass-production validation with a global chipmaker, and the company targets supply to a global customer within 2026.
Smallinsight Research's October 2026 report said further improvement is needed before earnings normalize, and that restored profitability and actual mass-production adoption of TGV and HBM equipment would mark the turning point for a re-rating.
Third-quarter 2026 revenue rose year on year, but the operating loss widened, so the second-half improvement the company described is not yet visible in profitability.